T cell-mediated rejection of kidney transplants: a personal viewpoint.

scientific article published on 23 March 2010

T cell-mediated rejection of kidney transplants: a personal viewpoint. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1600-6143.2010.03053.X
P698PubMed publication ID20346061
P5875ResearchGate publication ID42608795

P50authorPhilip F HalloranQ40000948
P2093author name stringP F Halloran
P2860cites workMolecular signatures distinguish human central memory from effector memory CD8 T cell subsetsQ28278055
Heterologous immunity provides a potent barrier to transplantation toleranceQ35095576
Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destructionQ36135190
Antigen presentation by human microvascular endothelial cells triggers ICAM-1-dependent transendothelial protrusion by, and fractalkine-dependent transendothelial migration of, effector memory CD4+ T cellsQ36731726
Vascular endothelial cells have impaired capacity to present immunodominant, antigenic peptides: a mechanism of cell type-specific immune escape.Q40460760
Interferon-gamma acts directly on rejecting renal allografts to prevent graft necrosisQ42856697
IFN-gamma alters the pathology of graft rejection: protection from early necrosisQ43628918
Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets.Q53521493
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)1126-1134
P577publication date2010-03-23
P1433published inAmerican Journal of TransplantationQ4744273
P1476titleT cell-mediated rejection of kidney transplants: a personal viewpoint
P478volume10

Reverse relations

cites work (P2860)
Q40278935Allo-HLA Cross-Reactivities of Cytomegalovirus-, Influenza-, and Varicella Zoster Virus-Specific Memory T Cells Are Shared by Different Healthy Individuals
Q50936985Alloimmune T cells in transplantation.
Q39829568An Integrated View of Molecular Changes, Histopathology and Outcomes in Kidney Transplants
Q100408260Angiotensin II type 1 receptor antibodies in kidney transplantation: An evidence-based comprehensive review
Q38813562Antitumor Activity of Total Flavonoids from Daphne genkwa in Colorectal Cancer
Q41634812Belatacept-based, ATG-Fresenius-induction regimen for kidney transplant recipients: a proof-of-concept study
Q42059394Bidirectional intragraft alloreactivity drives the repopulation of human intestinal allografts and correlates with clinical outcome.
Q35758302Bβ(15-42) attenuates the effect of ischemia-reperfusion injury in renal transplantation
Q40967497Chronic rejection: Differences and similarities in various solid organ transplants
Q48006232Comprehensive Analysis of Transcript Changes Associated With Allograft Rejection: Combining Universal and Selective Features.
Q35995043Derivation and validation of a cytokine-based assay to screen for acute rejection in renal transplant recipients
Q39513942Detection of Virus-Specific CD8+ T Cells With Cross-Reactivity Against Alloantigens: Potency and Flaws of Present Experimental Methods
Q34746535Differential effects of activated human renal epithelial cells on T-cell migration
Q35541507Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis
Q37798988Genomics in human renal transplantation
Q24305497Human renal tubular epithelial cells suppress alloreactive T cell proliferation
Q42740954Impact of acute rejection on kidney allograft outcomes in recipients on rapid steroid withdrawal
Q45913402Inhibition of intimal hyperplasia in murine aortic allografts by administration of a small-molecule TLR4 inhibitor TAK-242.
Q53181446Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsies.
Q30414748MicroRNAs as biomarkers in solid organ transplantation
Q47842670Minor H antigen matches and mismatches are equally distributed among recipients with or without complications after HLA identical sibling renal transplantation
Q46363554Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies
Q64118286Natural Killer Cells in Kidney Health and Disease
Q38228279Neutrophil gelatinase-associated lipocalin: ready for routine clinical use? An international perspective.
Q55373359One-year Allograft and Patient Survival in Renal Transplant Recipients Receiving Antiplatelet Therapy at the Time of Transplantation.
Q86779666Post-transplant soluble CD30 levels are associated with early subclinical rejection in kidney transplantation
Q42279035Potential impact of microarray diagnosis of T cell-mediated rejection in kidney transplants: The INTERCOM study
Q40289674Precision Subtypes of T Cell-Mediated Rejection Identified by Molecular Profiles
Q36238316Soothing touch of CD31 protects endothelium during cellular immune responses
Q94016517Specialized Roles of Human Natural Killer Cell Subsets in Kidney Transplant Rejection
Q92525927Suppressor of cytokine signaling genes in renal transplant receivers: Association with transplant fate
Q39395411Systems biology approach to transplant tolerance: proof of concept experiments using RNA interference (RNAi) to knock down hub genes in Jurkat and HeLa cells in vitro
Q98465673The Role of Natural Killer Cells in the Immune Response in Kidney Transplantation
Q36782862The Use of Genomics and Pathway Analysis in Our Understanding and Prediction of Clinical Renal Transplant Injury
Q39812222The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course.
Q38247690The significance of histological diagnosis in renal allograft biopsies in 2014.
Q50743724Using Molecular Phenotyping to Guide Improvements in the Histologic Diagnosis of T Cell-Mediated Rejection.

Search more.